Last updated: 19/March/2019
We applied the latest Microsoft security updates to the following products and confirmed no issue occurred. Please refer to the release note and security update guide for detail about the Microsoft security updates.
Products:
• Report Director Enterprise Ver. 8.2, Ver 9.x
• SVF for JavaPrint Ver. 8.2, Ver 9.x
• SVF for PDF(SVF for Web / PDF Java Edition) Ver. 8.2, Ver 9.x
• SVF for Web / Client Ver. 6.5a, Ver. 7.5, Ver. 8.2, Ver. 9.x
• Universal Connect / X Ver. 8.2, Ver 9.x
• Print Assistant Server Ver. 8.2, Ver 9.x
• PAlite Ver. 8.2, Ver 9.x
• SVF Web Direct Print PA Ver. 9.2
• SPA Ver. 9.3, Ver. 10.0
• Dr. Sum Ver. 5.0
• Dr.Sum EA Ver. 4.x
• Dr.Sum EA Datalizer Ver. 4.x (*1)
• MotionBoard Ver. 5.x (*2)
Evaluation was done on following operating systems:
Operating Systems:
- Windows Sever 2019 (BI product only)
- Windows Server 2008 R2
- Windows Server 2008
- Windows Server 2012
- Windows Server 2012 R2
- Windows Server 2016
- Windows 7
- Windows 8.1
- Windows 10
Note:
- Evaluation has been carried out under supported system requirement for each product.
- Security update for following products are out of scope in our verification testing since there is no technical dependency on our products:
SVF
- Team Foundation Server
- Skype for Business
- Microsoft Visual Studio
- NuGet
Dr. Sum/Dr. Sum EA/MotionBoard
- ChakraCore
- Team Foundation Server
- Skype for Business
- Microsoft Visual Studio
- NuGet
*1 We found an issue with Dr. Sum EA Datalizer when applying MS16-051 in May, 2016 and released a patch to address the issue. This verification was done after applying the patch.
*2 We found an issue with MotionBoard when applying MS16-022 in February, 2016 and released a patch to address the issue. This verification was done after applying the patch.
We found issues with Dr. Sum Datalizer and Dr. Sum EA Datalizer services when applying following Microsoft security updates which were released in July, 2018:
- 4338824
- 4338820
- 4338823
Refer to following articles for more detail and resolution:
Comments
0 comments
Please sign in to leave a comment.